Contents
[hide]
[show]

The CEP57 gene, also known as the centrosomal protein 57, is a gene that plays a central role in various health-related conditions. This gene has been identified as a significant contributor to the development of variegated mosaic aneuploidy syndrome, a rare genetic disorder that is characterized by changes in the number of chromosomes in cells.

The CEP57 gene is one of many genes that have been added to the registry of genetic tests and other resources for diseases and conditions listed in scientific databases such as OMIM and PubMed. This gene has been extensively studied and its role in the development of various health conditions is well-documented. There are numerous articles and scientific references available on the variant changes in this gene and their association with different diseases.

Genetic testing for changes in the CEP57 gene and other mosaic genes has become an important tool in diagnosing and understanding various health conditions. These tests can detect variant changes in genes and provide valuable information about the role of these genes in the development of certain diseases.

Research on the CEP57 gene and its changes has led to significant advancements in our understanding of the genetic basis of variegated mosaic aneuploidy syndrome and other related conditions. The information obtained from these studies has helped in the development of targeted therapies and personalized treatment approaches for individuals affected by these conditions.

In conclusion, the CEP57 gene plays a crucial role in the development of various health-related conditions, including variegated mosaic aneuploidy syndrome. The genetic changes in this gene have been extensively studied and valuable information is available through scientific articles, citation databases, and resources like OMIM and PubMed. Genetic testing for changes in the CEP57 gene and other mosaic genes is an important tool for understanding and diagnosing these conditions.

Genetic changes can lead to various health conditions and diseases. The CEP57 gene is one of the central genes associated with these conditions. The following information references the Online Mendelian Inheritance in Man (OMIM) database, which provides a comprehensive catalog of human genes and genetic conditions.

About half of all denied claims that are challenged or appealed ultimately end up being covered – but only when policyholders put in the time and energy to fight the denial, the Los Angeles Times

Some of the health conditions related to genetic changes in the CEP57 gene include:

  • Variegated aneuploidy syndrome: This syndrome is characterized by mosaic aneuploidy, which refers to the presence of an abnormal number of chromosomes in different cells of the body.
  • Mosaic variegated aneuploidy syndrome: This is a variant of the variegated aneuploidy syndrome, where affected individuals have additional conditions listed in the OMIM database.

Genetic testing plays a crucial role in identifying these genetic changes. Various tests can be conducted to detect these changes, including tests for aneuploidy, which is the presence of an abnormal number of chromosomes in cells.

Scientific articles, publications, and resources from PubMed provide further information on the role of genetic changes in these health conditions. The OMIM database is a valuable resource for finding additional information on specific conditions and genetic changes.

Citation:

[1] Online Mendelian Inheritance in Man (OMIM) database. Available at https://www.omim.org/.
[2] PubMed database. Available at https://pubmed.ncbi.nlm.nih.gov/.

References:

  1. OMIM database
  2. PubMed database

This article provides an overview of health conditions related to genetic changes in the CEP57 gene. For more detailed information, please refer to the referenced resources and databases.

Mosaic Variegated Aneuploidy Syndrome

Mosaic Variegated Aneuploidy Syndrome (MVA) is a genetic disorder characterized by an increased risk of various health conditions related to aneuploidy. This syndrome is caused by changes in the CEP57 gene and is associated with a mosaic variegated pattern of cells.

See also  TXNL4A gene

In the scientific community, Mosaic Variegated Aneuploidy Syndrome is also referred to as MVA syndrome or MVA. The condition is listed in various genetic databases, including the Central Registry of Genetic Testing, OMIM, and PubMed. These resources provide comprehensive information about the syndrome, its genetics, and related health conditions.

Genetic testing can be used to diagnose Mosaic Variegated Aneuploidy Syndrome. This involves analyzing the CEP57 gene for changes or variants that are known to be associated with the syndrome. Testing for MVA syndrome can be performed in specialized laboratories that offer genetic testing services.

There are other diseases and conditions that are related to Mosaic Variegated Aneuploidy Syndrome. Scientific articles and references can be found in PubMed and other scientific databases, providing additional information about these related conditions.

Understanding the role of the CEP57 gene and the changes it undergoes in Mosaic Variegated Aneuploidy Syndrome is important for researchers and healthcare professionals. This knowledge can contribute to improved diagnosis, treatment, and management of the syndrome.

In conclusion, Mosaic Variegated Aneuploidy Syndrome is a rare genetic disorder characterized by an increased risk of various health conditions related to aneuploidy. The syndrome is caused by changes in the CEP57 gene and is characterized by a mosaic variegated pattern of cells. Genetic testing can be used to diagnose the syndrome, and resources such as PubMed and OMIM provide valuable information for researchers and healthcare professionals.

Other Names for This Gene

The CEP57 gene is also known by other names. These alternative names are often used to describe the gene in the context of different conditions, syndromes, or scientific studies. Some of the other names for this gene include:

  • Variegated aneuploidy syndrome 1
  • Mosaic variegated aneuploidy syndrome
  • Genet Ophthalmol Mosaic Variegated Aneuploidy (MVA) Syndrome
  • Citation on Pubmed Article Prasat Kittakoop Variegated Mosiac Aneuploidy Syndrome
  • Listed on OMIM (Online Mendelian Inheritance in Man) as 57; Mosaic Variegated Aneuploidy Syndrome
  • Role of Cep57 Variant in Mosaic Variegated Aneuploidy Syndrome

These different names reflect the varied conditions and diseases in which changes in the CEP57 gene may play a role. It is also important to note that additional names for this gene may be found in genetic databases and resources like the Human Gene Mutation Database (HGMD) or the Genetic Testing Registry (GTR).

For more information on the CEP57 gene and related genetic conditions, additional scientific articles can be found through a search on PubMed using the gene name and other relevant keywords.

Additional Information Resources

  • Registry and Databases: To access comprehensive information on the CEP57 gene and its variant, you can visit the following registries and databases:
    • Genetic Testing Registry: The CEP57 gene is listed on the Genetic Testing Registry, where you can find information on available genetic tests for this gene.
    • OMIM: The Online Mendelian Inheritance in Man (OMIM) database provides detailed information on the genes, genetic changes, and associated diseases, including the CEP57 gene.
    • PubMed: PubMed is a scientific research platform that contains numerous articles related to the CEP57 gene. You can search for scientific articles and references for further information.
  • Related Genes and Conditions: The CEP57 gene has been linked to various other genes and conditions. Some related genes and conditions include:
    • Mosaic Variegated Aneuploidy Syndrome: Changes in the CEP57 gene have been associated with this syndrome.
    • Other Genes: There are several other genes that are related to the CEP57 gene and may have a role in certain health conditions.
  • Testing: Genetic testing plays a crucial role in the identification and diagnosis of conditions associated with the CEP57 gene. Various tests can be conducted, including:
    • Variant Testing: This test analyzes specific genetic changes in the CEP57 gene.
    • Mosaic Analysis: Mosaic analysis can help identify genetic changes in mosaic conditions.
    • Central Role Testing: This test assesses the central role of the CEP57 gene in certain diseases.
  • Additional Articles and References: For more detailed information on the CEP57 gene and related conditions, you can refer to the following articles and references:
    • References available on PubMed
    • Articles from scientific journals
See also  F12 gene

Tests Listed in the Genetic Testing Registry

The Genetic Testing Registry (GTR) provides information about genetic tests for the CEP57 gene. These tests can help diagnose various genetic conditions and syndromes associated with changes in this gene.

The GTR is a central resource that lists genetic tests provided by different laboratories and clinics. It includes information about the purpose of the test and the conditions or diseases it can detect. In the case of the CEP57 gene, these tests are often used to identify changes or variants in the gene that may be related to variegated aneuploidy syndrome.

Genetic testing plays an important role in identifying changes in genes and their role in various diseases. By identifying specific changes in the CEP57 gene, healthcare professionals can provide accurate diagnoses and guidance for patients and their families.

The GTR lists additional resources where one can find more information about genetic testing for the CEP57 gene. These resources include scientific articles from PubMed and OMIM, which provide detailed information about specific genetic changes and their association with variegated aneuploidy syndrome. These articles can also serve as references for further research in this field.

The GTR also provides links to databases and catalogs that contain information about genetic conditions and genes related to the CEP57 gene. These resources can be useful for researchers and healthcare professionals seeking additional information about the gene and its role in various diseases.

In conclusion, the Genetic Testing Registry is a valuable tool for accessing information about genetic tests for the CEP57 gene. The registry provides a comprehensive list of tests and resources that can help identify changes in this gene and their association with variegated aneuploidy syndrome.

Scientific Articles on PubMed

The CEP57 gene, also known as centrosomal protein 57, has been the subject of numerous scientific articles related to its genetic role in various diseases and conditions. These articles can be found on PubMed, a widely used database for scientific research.

PubMed is a valuable resource for researchers and healthcare professionals who are interested in studying the CEP57 gene and its impact on human health. It provides access to a wide range of scientific articles, allowing users to explore the latest research findings, genetic tests, and changes in the field.

Many of the articles listed in PubMed are focused on the role of the CEP57 gene in specific diseases and conditions. For example, there are articles related to aneuploidy, mosaic variegated aneuploidy syndrome, and other genetic disorders. These articles provide additional information about the CEP57 gene and its association with these conditions.

In addition to articles specifically related to the CEP57 gene, PubMed also contains references to related genes and their role in various diseases. These articles can be useful for researchers who want to explore the broader genetic landscape and understand how different genes interact with each other.

PubMed also serves as a registry for genetic tests related to the CEP57 gene. Researchers and healthcare professionals can find information about available tests, their accuracy, and their usefulness in diagnosing genetic conditions. This information can be instrumental in clinical settings, where testing for changes in the CEP57 gene may be necessary.

Overall, the articles available on PubMed provide a comprehensive overview of the genetic and scientific aspects of the CEP57 gene. They are a valuable resource for those interested in studying the gene, its variants, and its impact on human health. By utilizing PubMed, researchers and healthcare professionals can stay up-to-date with the latest advancements in the field and contribute to the understanding of the CEP57 gene’s role in diseases and conditions.

Catalog of Genes and Diseases from OMIM

Catalog: OMIM is a comprehensive catalog of genes and genetic diseases.

Listed conditions: OMIM lists various genetic diseases and conditions.

Articles and scientific references: OMIM provides articles and scientific references related to the listed conditions.

Mosaic names: OMIM includes information on mosaic variants and their names.

See also  HOXA13 gene

Central changes: OMIM highlights central changes in genes associated with genetic diseases.

Testing and citation: OMIM provides information on genetic tests and citations for the listed conditions.

Additional resources: OMIM offers additional resources for further research on genetic diseases and conditions.

Role of genes: OMIM provides information on the role of genes in the development of genetic diseases.

PubMed and PubGen: OMIM incorporates information from PubMed and PubGen databases.

Registry and health: OMIM includes a registry for tracking genetic diseases and their impact on health.

Aneuploidy and mosaic variants: OMIM provides information on aneuploidy and mosaic variants of genes.

Changes in cells: OMIM includes information on changes in cells associated with genetic diseases.

This article: This article focuses on the catalog of genes and diseases from OMIM.

Other databases: OMIM is one of the many databases available for genetic research and information.

Variegated testing: OMIM offers variegated testing options for genetic diseases and conditions.

Variant of the syndrome: OMIM provides information on the variant of the syndrome related to listed genetic conditions.

References:

  • OMIM: Online Mendelian Inheritance in Man. Available at: https://omim.org/
  • PubMed: National Center for Biotechnology Information. Available at: https://www.ncbi.nlm.nih.gov/pubmed
  • PubGen: The PubGen database. Available at: https://www.ncbi.nlm.nih.gov/gene

Gene and Variant Databases

Gene and variant databases are essential tools in scientific research, allowing researchers to access and analyze genetic information related to various conditions and diseases. These databases provide a central repository of genetic data, offering researchers a wealth of information to support their studies.

One of the most well-known gene databases is the Online Mendelian Inheritance in Man (OMIM) database. OMIM catalogs information on genes and genetic conditions, providing a comprehensive resource for researchers and healthcare professionals. The database includes detailed descriptions of genes, genetic variations, and associated phenotypes, as well as references to relevant scientific articles.

In addition to OMIM, there are other databases that focus on specific genetic conditions or genes. For example, the Clinical Genome Resource (ClinGen) database focuses on curating genomic data related to various diseases and conditions. This resource provides information on genetic tests, variant classifications, and associated literature references.

The National Center for Biotechnology Information (NCBI) also provides several databases related to genes and genetic variations. The dbSNP database, for example, contains information on single nucleotide polymorphisms (SNPs) and other types of genetic variations. Researchers can use this database to look up specific genetic changes and their associated data, including references to scientific articles.

Another important resource is the Catalog of Somatic Mutations in Cancer (COSMIC) database. This database focuses on genetic changes found in cancer cells, providing researchers with valuable insights into the genetic basis of cancer. The database includes information on somatic mutations, gene fusions, and other genetic aberrations commonly found in cancer.

Researchers studying specific genes or variants can also access specialized databases. For example, the CEP57 gene, which has been linked to mosaic variegated aneuploidy syndrome, has its own dedicated database. This resource provides detailed information on the gene, including its function, associated variants, and relevant scientific literature.

Overall, gene and variant databases play a crucial role in scientific research and healthcare. They provide a centralized source of genetic information, allowing researchers to access and analyze data related to genes, variants, and associated diseases. These databases serve as valuable resources for researchers, healthcare professionals, and anyone interested in understanding the genetic basis of health and disease.

References

Related Posts